Glucagon-like peptide-1 (GLP-1) peptides have emerged as a compelling therapeutic avenue for managing metabolic conditions. These naturally occurring molecules are secreted by the gut in response to meal intake, stimulating insulin production and suppressing glucagon secretion. GLP-1 derivatives exhibit promising therapeutic efficacy in treating ty… Read More